Sympatholytic & adrenergic blockers -receptor Antagonists

Slides:



Advertisements
Similar presentations
Catecholamine Agonists and Antagonists. Need-to-know Drugs Norepinephrine Norepinephrine Alpha 1 & 2 and Beta 1 agonist Alpha 1 & 2 and Beta 1 agonist.
Advertisements

Sympathetic Drugs. Stress and The Adrenal Glands.
Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 )
Pharmacology II The Autonomic Nervous System Adrenergic antagonists
Hypertension. Normal BP:120.
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
Alpha-Adrenergic Blockers
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Adrenergic Blockers Asmah Nasser, M.D..
Joseph De Soto MD, PhD, FAIC. Overview The adrenergic antagonist bind adrenoreceptors either reversibly or irreversibly preventing or reducing activation.
Adrenoceptor Blockers
Drugs Affecting the Sympathetic Nervous System
ADRENERGIC ANTAGONITS
Alpha Adrenergic receptor blockers
Adrenergic antagonist sympatholytic
Adrenergic Antagonist (Sympatholytics)
ADRENERGIC MEDICATIONS (sympathomimetic drugs) BY:DR.ISRAA OMAR.
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 19 Indirect-Acting Antiadrenergic Agents.
SYMPATHOMIMETICS Classification: A- According to the source:
ANTI-ADRENERGIC DRUGS
AUTONOMIC SYSTEMS AND DRUGS-2
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Adrenolytics. Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics Alpha & beta- adrenergic receptor blockers.
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
Synthesis & Release of Neurotransmitters
 Cardiovascular Effects  α -receptor antagonist drugs lower peripheral vascular resistance and blood pressure.  These drugs can prevent the pressor.
Cardiovascular drugs By Dr. fatmah alomary
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 46 Vasodilators.
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
Adrenoceptor antagonist drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology) Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Adrenergic Antagonists (Sympatholytics)
بسم الله الرحمن الرحيم.
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Sympathetic Nervous System.
Adrenergic Antagonists
PHARMACOLOGY OFADRENERGICS
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
Drug action on Sympathetic Nerves: No. 3: Sympatholytic drugs
Adrenergic Receptor Antagonists These are drugs which antagonize α or β or both α and β adrenergic receptors Adrenergic neurone blocking agents (Sympatholytic)
 Prazosin, doxazosin, and terazosin  They causing relaxation of both arterial and venous smooth muscle. Postural hypotension may occur in some individuals.
Adrenergic Antagonists (Sympatholytics). Basic stages in synaptic transmission.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonists
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
Sympatholytic & adrenergic blockers -receptor Antagonists
PHARMACOLOGY OFADRENERGICS
Sympatholytic & adrenergic blockers -receptor Antagonists
Drugs for Hypertension
Sympatholytic & adrenergic blockers -receptor Antagonists
Antihypertensive Drugs
Drugs for Autonomic Nervous System
Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia
Adrenergic agonists.
Adrenergic antagonists
Adrenergic antagonists
Characteristics of Adrenergic Drugs (p. 291)
جامعة الملك فيصل كلية الصيدلة الإكلينيكية College of Clinical PharmacyKing Faisal University جامعة الملك فيصل كلية الصيدلة الإكلينيكية College of Clinical.
Effect of β-adrenergic Blockers on the Arterial Blood Pressure
Adrenergic agonists and antagonists
Adrenergic Antagonists
SNS Drugs Anita Bolina 23rd March 2019.
- Adrenoceptors blockers
Adrenergic Antagonist
Sympatholytic Drugs Adrenergic neuron blockers Adrenergic receptor
Adrenergic Antagonists
Chaper 20 Adrenoceptor Antagonists
Adrenergic antagonists I (alpha blockers)
Presentation transcript:

Sympatholytic & adrenergic blockers -receptor Antagonists Prof. Hanan Hagar Pharmacology Unit College of Medicine

By the end of this lecture, the student should be able to Outline the mechanisms of action of adrenergic neuron blockers Classify -receptor blockers into selective & non- selective Know the pharmacokinetic aspects & pharmacodynamic effects of  adrenergic blockers. Identify the specific uses of non selective and selective  -adrenergic blockers.

Adrenoceptor Blockers Adrenergic Neuron Blockers Alpha & beta- adrenergic receptor blockers

Classification of sympatholytics Adrenergic neuron blockers Adrenergic receptor blockers

Classification of sympatholytics Adrenergic receptor blockers -receptor antagonists β-receptor antagonists

Classification of sympatholytics Adrenergic neuron blockers Formation of False Transmitters e.g. a-Methyl dopa Depletion of storage sites e.g. reserpine Inhibition of release & enhance uptake e.g. guanethidine Stimulation of presynaptic a2 receptors e.g. Clonidine and a-Methyl dopa

mechanisms of Adrenergic blockers a-Methyl dopa Formation of False Transmitters

mechanisms of Adrenergic blockers Inhibition of release Guanethidine

mechanisms of Adrenergic blockers Stimulation of presynaptic a2 receptors Clonidine and a-Methyldopa

mechanisms of Adrenergic blockers Interferes with NA storage RESERPINE

Adrenergic neuron blockers a-Methyl dopa Forms false transmitter that is released instead of NE Acts as central a2 receptor agonist to inhibit NE release Drug of choice in Treatment of hypertension in pregnancy ( gestational hypertension & pre-eclampsia ).

Classification of sympatholytics Clonidine Acts as central a2 receptor agonist to inhibit NE release suppresses sympathetic outflow activity from the brain. Little used as antihypertensive agent due to rebound hypertension upon abrupt withdrawal. Apraclonidine is used in open angle glaucoma as eye drops. acts by decreasing aqueous humor formation.

2. Adrenoceptor Blockers [ADRENOLYTICS] 1. Adrenergic Neuron Blockers [SYMPATHOLYTICS] 1. METHYLDOPA a-methyl tyrosine Norepinephrine (NE) Na Tyrosine False Transmitters Dopa Tyrosine  Antihypertensive in PREGNANCY DA 2. RESERPINE NE Depletes Stores a2 a1 b1 b2 NET 4. Clonidine Presynaptic a2 agonist 3. Gaunthidine  Inhibit Release  Enhance Uptake 2. Adrenoceptor Blockers [ADRENOLYTICS] COMT

Adrenergic receptor blockers Include -receptor antagonists β-receptor antagonists

Classification of -receptor Antagonists Non-selective antagonists e.g. phenoxybenzamine & phentolamine. 1-selective antagonists e.g. prazosin, doxazosin. 2-selective antagonists e.g. yohimbine

Non-Selective - Adrenoceptor Antagonists Phenoxybenzamine: Irreversible block of both 1 and 2 receptors Long-acting (24 hrs) Phentolamine: reversible blocking of 1 & 2 receptors. Short acting (4 hrs).

Pharmacological actions Both drugs cause: Decrease peripheral vascular resistance Postural hypotension. Reflex tachycardia. Reflex tachycardia due to the fall in B.P, mediated by baroreceptor reflex and due to block 2 in heart.

Therapeutic Uses: Pheochromocytoma: Should be given before surgical removal to protect against hypertensive crisis.

Contraindicated: Both drugs can precipitate arrhythmias and angina and are contra-indicated in patients with decreased coronary perfusion.

Adverse Effects of non-Selective - Adrenoceptor Antagonists : Postural hypotension Tachycardia Headache Nasal stuffiness or congestion Vertigo & drowsiness Male sexual dysfunction (inhibits ejaculation).

Selective 1- Antagonists Prazosin, Doxazosin, Terazosin Prazosin (short half-life) Doxazosin, terazosin (long half life)

Selective 1- Antagonists Pharmacological effects of 1–antagonists: Vasodilatation due to relaxation of arterial and venous smooth muscles Fall in arterial pressure less reflex tachycardia than with non-selective  blockers

Selective 1- Antagonists

Therapeutic Uses: Urinary obstruction of benign prostatic hypertrophy (BPH). Treatment of essential hypertension with prostate enlargement.

Therapeutic Uses: Reynaud's disease: causes fingers and toes to feel numb and cold in response to cold temperature.

Selective 1A–antagonists Tamsulosin Is a selective 1A antagonist. 1A receptors present in prostate Causes relaxation of smooth muscles of bladder neck & prostate →improve urine flow. Has minimal effect on blood pressure. Is used in the treatment of benign prostatic hypertrophy (BPH).

Selective 1A antagonist Tamsulosin BPH Tamsulosin Relaxation of bladder neck can improve urine flow Adverse effects of 1A- Antagonists as before with non selective but to a lesser degree

2-selective antagonists e.g. yohimbine Used as aphrodisiac in the treatment of erectile dysfunction. Increase nitric oxide released in the corpus cavernosum thus producing vasodilator action and contributing to the erectile process.

Synopsis Adrenergic neuron blockers α-Methyldopa Reserpine False neurotransmiter formation α-Methyldopa Depletion of stores Reserpine Inhibition of release Guanethidine Stimulation of presynaptic α-receptors Clonidine Synopsis

SUMMARY